Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen Barlas

Showing results (111-120 of 149) with videos related to

Pageof 15
Sort By:
P & T : a Peer-Reviewed Journal for Formulary Management|June 14, 2018
Congress Moves Toward Opioid Response 2.0: Bills Are Wide Ranging and Well Intentioned but Mostly LightweightStephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management|February 16, 2019
Latest Opioid Abuse Bill Contains Over 100 Provisions But No Far-Reaching Pharmacy MandatesStephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management|June 5, 2019
A Drug Pricing "Transparency" Bill With Strong Bipartisan Support But Would It Accomplish Much?Stephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management|June 6, 2015
The FDA may change pharmacists' access to prescribing information: a website would replace paper package insertsStephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management|May 20, 2015
Precision medicine initiative aims for a new generation of diagnostics and treatments: but is the promise of genetic targeting overinflated?Stephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management|April 7, 2017
Republicans Resolve to Address High Drug Prices: Rhetoric Meets Reality With PPACA ReplacementStephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management|April 24, 2014
The pharmaceutical industry tussles over biosimilars: federal and state decisions will have a big impact on pharmacistsStephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management|January 17, 2017
Plan to Settle 340B Disputes Elicits Dispute: Roadblocks Remain to Quieting Drug Pricing ControversiesStephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management|March 27, 2014
Hospitals have an extra year to meet stage 2 meaningful use standards: american hospital association wants new concessionsStephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management|March 5, 2019
Do GPOs Play a Role in Drug Shortages? Long-Standing Allegations Disputed by The GPOsStephen Barlas
Pageof 15

Showing results (111-120 of 149) with videos related to

Sort By:
Pageof 15
P & T : a Peer-Reviewed Journal for Formulary Management|June 14, 2018
Congress Moves Toward Opioid Response 2.0: Bills Are Wide Ranging and Well Intentioned but Mostly LightweightStephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management|February 16, 2019
Latest Opioid Abuse Bill Contains Over 100 Provisions But No Far-Reaching Pharmacy MandatesStephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management|June 5, 2019
A Drug Pricing "Transparency" Bill With Strong Bipartisan Support But Would It Accomplish Much?Stephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management|June 6, 2015
The FDA may change pharmacists' access to prescribing information: a website would replace paper package insertsStephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management|May 20, 2015
Precision medicine initiative aims for a new generation of diagnostics and treatments: but is the promise of genetic targeting overinflated?Stephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management|April 7, 2017
Republicans Resolve to Address High Drug Prices: Rhetoric Meets Reality With PPACA ReplacementStephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management|April 24, 2014
The pharmaceutical industry tussles over biosimilars: federal and state decisions will have a big impact on pharmacistsStephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management|January 17, 2017
Plan to Settle 340B Disputes Elicits Dispute: Roadblocks Remain to Quieting Drug Pricing ControversiesStephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management|March 27, 2014
Hospitals have an extra year to meet stage 2 meaningful use standards: american hospital association wants new concessionsStephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management|March 5, 2019
Do GPOs Play a Role in Drug Shortages? Long-Standing Allegations Disputed by The GPOsStephen Barlas
Pageof 15